[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 9, Issue 1 (1-2018) ::
Caspian J Intern Med 2018, 9(1): 65-70 Back to browse issues page
BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran
Hossein Ayatollahi, Mohammadreza Keramati, Abbass Shirdel, Mohammadmehdi Kooshyar, Majid Raeiszadeh, Sepideh Shakeri, Mohammadhadi Sadeghian *, Fatemeh Shams
Cancer Molecular Pathology Research Center, Department of Hematology and Blood Bank, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. , sadeghianmh@mums.ac.ir
Abstract:   (2402 Views)
Background: A specific chromosomal abnormality, the Philadelphia chromosome (BCR-ABL fusion), is present in all patients with chronic myeloid leukemia (CML). The b2a2 and b3a2 fusion mRNAs encode p210 fusion protein p210 and e1a2 encode p190. The aim of this study was to evaluate the frequency of BCR-ABL fusion transcript variants in Northeast of Iranian CML patients and to compare the laboratory results of our patients.
Methods: This study was conducted in 85 peripheral blood and bone marrow samples of CML patients. Ribonucleic acid (RNA) was extracted by a commercial kit, RT- PCR for identifying BCR-ABL fusions was carried out by using designed primers and the PCR products were electrophoresed in agarose gels. Finally, statistical analysis was performed for variant frequency identification and their comparison was performed.
Results: All patients examined were positive for BCR/ABL rearrangement. Fusion of b3a2 was detected in 53 (62.35%) patients, b2a2 in 25 (29.41), e1a2 in 1 (1.17%) and coexpression of b3a2 and e1a2 in 6 (7.05%) patients. There were significant differences between the mean age in patients with b3a2 positive ( 44.07 years) and in b3a2 negative group (50.35 years) however, no significant differences were seen between sex and b2a2 (P=0.61), b3a2 (P=0.79) and e1a2 (P=0.20).
Conclusions: This study showed higher frequency b3a2 than b2a2 and e1a2 transcripts in CML patients in Northeast Iran and there was no association between e1a2 transcripts frequencies and monocytosis in peripheral blood

Keywords: BCR-ABL, RT-PCR, chronic myeloid leukemia, Iran
Full-Text [PDF 293 kb]   (398 Downloads)    
Type of Study: Original Article | Subject: Hematology
Received: 2016/07/24 | Accepted: 2017/08/19 | Published: 2017/10/18
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ayatollahi H, Keramati M, Shirdel A, Kooshyar M, Raeiszadeh M, Shakeri S, et al . BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran. Caspian J Intern Med. 2018; 9 (1) :65-70
URL: http://caspjim.com/article-1-825-en.html


Volume 9, Issue 1 (1-2018) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 3937